| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


( Institute of Microbiology, Rutgers, The State University, New Brunswick, N.J.)
The ability of actinomycin D to exert a significant therapeutic effect on two types of ascitic tumors in the mouse is described. The inclusion of actinomycin as a positive control in antitumor screening is suggested.
* Aided by a grant from the United States Public Health Services, C-2716.
Present address: The Wyeth Institute for Medical Research, Radnor, Pa.
Present address: The Kitasato Institute for Infectious Diseases, Tokyo, Japan.
Received 7/11/56.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |